Understanding health outcomes and pharmacoeconomics / [edited by] George E. MacKinnon III.
Material type:
TextPublisher: Burlington, MA : Jones & Bartlett Learning, [2013]Copyright date: ©2013. Description: xxii, 218 pages : illustrations ; 23 cmContent type: - text
- unmediated
- volume
- 9780763770990 (pbk. : alk. paper)
- 338.476151 23 U.
- RS100 .U53 2013
- QV 736
Contents:
Summary: Understanding Health Outcomes and Pharmacoeconomics presents an overview of the tools used to assess patient-related health status including associated health outcomes and the analyses that are used to determine cost-effectiveness in evaluating pharmacotherapeutic interventions to improve health. Including data and examples from several different countries, this comprehensive text will help students understand the basis for decisions made at the local and governmental level that impact the use of pharmaceuticals and provide a strong foundation for understanding the principles used in cost-effective decision making. With commentaries, cases studies, and highlighting international differences, this text concludes with a discussion of the need for a universal system for documenting medication use. Understanding Health Outcomes and Pharmacoeconomics provides definitions of comparative effectiveness research (CER) and comparisons of pharmacoeconomic models (including cost-effectivess, cost-benefit, and cost utility analyses). This inclusive text provides describes how CER is linked to various pharmacoeconomic models by providing examples from clinical trials with comparative pharmacotherapy and cost parameters. From the Introduction: "The need for interprofessional education was made apparent in the 2003 Health Professions Education: A Bridge to Quality report. All healthcare professionals must be educated to deliver patient-centered care as members of an interprofessional team, emphasizing evidence-based practice, quality improvement approaches, and informatics. An enhanced understanding of pharmacoeconomic principles is a step in the right direction for healthcare practitioners as we do our best to ensure optimal medication therapy outcomes for patients and society at-large."
| Item type | Current library | Collection | Call number | Status | Date due | Barcode |
|---|---|---|---|---|---|---|
Books
|
Main library A5 | Pharmacy ( Clinical Pharmacy ) | 338.476151 U. (Browse shelf(Opens below)) | Available | 00010545 |
Browsing Main library shelves, Shelving location: A5 Close shelf browser (Hides shelf browser)
| No cover image available | ||||||||
| 338.476151 A.E.P Plant biotechnologies and pharmaceutical products / | 338.476151 R.K.E Essentials of pharmacoeconomics / | 338.476151 S.R.I International pharmaceutical services : the drug industry and pharmacy practice in twenty-three major countries of the world / | 338.476151 U. Understanding health outcomes and pharmacoeconomics / | 338.47621382 J.R.I Industrial economics and telecommunication regulations / | 338.47624 H.P.E Economic theory and the construction industry / | 338.47624 M.D.C Construction economics : a new approach / |
Includes bibliographical references and index.
Drug approval process --
Measuring health status and health-related quality of life assessment --
Health surveys (disease specific and generic questionnaires) and utility assessment --
Overview of statistical analyses in biomedical research --
Randomized clinical trials --
Systematic reviews and meta analyses --
Medical and prescription claims databases --
Uses of patient registries in evidence development --
Decision analysis --
Introduction to economic analysis, cost determinants and modeling --
Cost-of-illness analysis and budget impact models --
Cost-benefit analysis, cost-effectiveness analysis and cost-utility analysis --
Comparative effectiveness.
Understanding Health Outcomes and Pharmacoeconomics presents an overview of the tools used to assess patient-related health status including associated health outcomes and the analyses that are used to determine cost-effectiveness in evaluating pharmacotherapeutic interventions to improve health. Including data and examples from several different countries, this comprehensive text will help students understand the basis for decisions made at the local and governmental level that impact the use of pharmaceuticals and provide a strong foundation for understanding the principles used in cost-effective decision making. With commentaries, cases studies, and highlighting international differences, this text concludes with a discussion of the need for a universal system for documenting medication use. Understanding Health Outcomes and Pharmacoeconomics provides definitions of comparative effectiveness research (CER) and comparisons of pharmacoeconomic models (including cost-effectivess, cost-benefit, and cost utility analyses). This inclusive text provides describes how CER is linked to various pharmacoeconomic models by providing examples from clinical trials with comparative pharmacotherapy and cost parameters. From the Introduction: "The need for interprofessional education was made apparent in the 2003 Health Professions Education: A Bridge to Quality report. All healthcare professionals must be educated to deliver patient-centered care as members of an interprofessional team, emphasizing evidence-based practice, quality improvement approaches, and informatics. An enhanced understanding of pharmacoeconomic principles is a step in the right direction for healthcare practitioners as we do our best to ensure optimal medication therapy outcomes for patients and society at-large."
There are no comments on this title.